CNS study challenges demand insightful planning
Recruitment difficulties, subjective outcome measures, treatment adherence issues—these hurdles can be anticipated and overcome. Careful planning is rewarded.
Navigate the challenges of your CNS studies
Quintiles can help you reduce costs, accelerate timelines and manage risk in your central nervous system programs. Our approach is to partner with you to plan and implement any CNS initiative, from Alzheimer’s trials to pain studies, applying our broad and deep CNS expertise at every stage of the process.
With a team of experts and a data-driven approach, complications can be avoided and obstacles can be eliminated all along the way:
- Clinical development. Leverage our proficiency in protocol design, biomarker strategies and diagnostic imaging technologies to open new doors for CNS research.
- Trial operations. Accelerate recruitment and streamline trials with our global medical and operational staff.
- Outcomes reporting. Explore the nuances of subjective outcomes by drawing on the insight of our trained investigators.
- Commercial strategies. Speed market entry with the support of sales and marketing specialists who have neuroscience experience.
Access a deep CNS knowledge base
Quintiles helped develop or commercialize 100% of the top 50 best-selling CNS products or compounds. Our centers of excellence include acute care and pain, autism, neurology and psychiatry. Our deep knowledge includes psychological and neurological disorders, including: ADHD, bipolar disorders, multiple sclerosis, sleep disorders, addiction disorders, depression, pain, stroke, Alzheimer’s disease, epilepsy, Parkinson’s disease, anxiety, migraine and schizophrenia.
Our success in central nervous system research can be seen in the success of our customers. By helping them anticipate and overcome obstacles, they’ve been able to successfully bring new therapies to market.